|Back to main|
CEO of Alexion Pharmaceuticals Inc. Leonard Bell Sold 140,000 Shares
8/19/2013 1:24:00 PM
Alexion Pharmaceuticals Inc. is a biopharmaceutical company
focused on serving patients with severe and ultra-rare disorders
through the innovation, development and commercialization of
life-transforming therapeutic products. The company has a market
cap of $20.53 billion; its shares were traded at around $105.00
with a P/E ratio of 59.52 and P/S ratio of 15.89. Alexion
Pharmaceuticals Inc. had an annual average earnings growth of 70.6%
over the past five years.
About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .